openPR Logo
Press release

Pulsed High-Dose Magnetic Fields of More Than 1000 Gauss Generated with the Magcell® Arthro From Physio Equipment in UK

12-01-2017 09:32 AM CET | Health & Medicine

Press release from: PhysioPod UK Limited

With the MAGCELL® ARTHRO movement of electrically charged particles increases the concentration of ferromagnetic elements in the blood, producing a significant increase in the partial pressure of oxygen (PO2) in the treated area.

Nottingham, Nottinghamshire, United Kingdom., November 30, 2017 -- Electrotherapy without electrodes is a transmission medium for electric fields inducing a current intensity of up to 10 mA/cm2 in the conductive tissue. This causes an increase of up to 30% of the peripheral blood flow that can be detected immediately and prevents complications caused by a reduced arterial blood risk.

The MAGCELL® ARTHRO is used in regeneration of areas of the locomotor system (bone fractures, trauma, contusions, sprains, vertebral injuries, tendinopathies, ligamentous strains, muscular metabolism abnormalities, pain) and postoperatively."

MAGCELL® ARTHRO significantly improves general symptoms (WOMAC total score) and individual scores for pain, stiffness and daily activity in osteoarthritis (ARC criteria II and III). The therapy can be applied several times daily as a complementary treatment without side effects and may thus help to reduce intake of pain medication

- Very easy one-button operation
- Battery-driven
- Optical and acoustic function control
- Automatic switch-off at the end of the therapy period

Therapy Information

Through a patent-registered, innovative procedure, MAGCELL® ARTHRO is able to create exceptionally strong pulsating magnetic fields of up to 100 mT (1000 gauss) with selective frequency ranges despite its small size. Time-variable magnetic fields can function as transfer media for electric fields. Providing that – like MAGCELL® ARTHRO – the field force is sufficiently high, electro-magnetic fields can be induced in the tissue beyond the internationally recognised threshold for biological effectiveness. Through the possibility of direct application and the resulting close distance of the magnetic field to the application area, MAGCELL® ARTHRO also ensures minimum loss of magnetic field strength, transporting it deep into the tissue layers (electrode-free electrotherapy). Its battery operation and thus constant readiness enables the execution of a therapy programme through repeated short treatments in contrast to treatments previously only offered in doctor’s surgeries.

MAGCELL® ARTHRO is ideal for painful hip, knee and jaw joint arthritis, Hallux rigidus and valgus and a range of other arthritic conditions. Clinical studies on the complementary use of MAGCELL® ARTHRO for acute knee arthritis (1,2) have shown that amongst others, the following clinical effects can be achieved:

- Significant relief from inflammation pain
- Improvement in joint movement
- Reduction of knee joint circumference
- Significant reduction of WOMAC index

In a randomised controlled study on the effect of MAGCELL® ARTHRO for knee arthritis with osteoarthritis level 2.8±0.8 (American College of Rheumatology criteria) at the primary clinical end point (WOMAC total score) median increase of 0.7 P (non-significant) was recorded in the placebo group between T0 and T1 (18 days), yet in the MAGCELL®-group a significant local decrease of 21.8 P. During the study no undesirable incidents or side effects occurred related to therapy.
 
Magnetic field therapy is available in a range of types and appearances. Various forms of therapy do not have sufficient scientific proof of their effectiveness. The MAGCELL® ARTHRO medical product cannot be compared with ‘pulsating signal therapy (PST)’, ‘MultiBioSignal Therapy (MBST)’, ‘Nuclear Magnetic Resonance Therapy’, ‘TENS' or other transmission forms such as magnetic field mats or coils.

MAGCELL® ARTHRO works with therapy parameters investigated in empirical and clinical research. There are no known side effects or intolerance associated with the use of MAGCELL® ARTHRO. Based on a large amount of patient feedback, regular therapy may enable reductions in the dosage of medication, such as non-steroidal anti-rheumatic agents.

1 Hitrov N, Portnov V (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3:25-27.
2 Wuschech H, et al. (2009): Effekte von PEMF bei Patienten mit Arthrose: Ergebnisse einer prospektiven, randomisierten, plazebokontrollierten, doppel-blinden Studie. Publication in progress.

About PhysioPod UK Limited and Physio Equipment:
Company incorporation of PhysioPod® UK Ltd took place in July 2006, when the company was set up to exclusively supply DEEP OSCILLATION®, an unknown treatment modality in the UK and the Republic of Ireland.  In 2011, the PhysioPod® company name was trademarked, due to its recognition within healthcare and in 2012DEEP OSCILLATION® into many NHS Lymphoedema services, to private practitioners and to patients self-managing Lymphoedema and Lipoedema symptoms at home and abroad with the personal unit.

In 2016, they were delighted to receive the ‘Global Healthcare and Pharmaceutical Award for Healthcare Innovation' with DEEP OSCILLATION® therapy, which is just one of the high quality, cutting-edge products available from manufacturers PHYSIOMED Elektromedizin AG, who hold a very strong position in Germany and export their products to 83 countries worldwide.

Julie Soroczyn heads up the company as Managing Director, with a wide and varied background including retail management, hospitality and an instructor of dance and aerobics. As a natural progression, Julie qualified in complementary therapies and sports & remedial massage and was introduced to DEEP OSCILLATION® by a sports lecturer in 2006. Mary Fickling has experience in both retail and office management and finance, both within the TV/Film industry sector and the motor trade. Together with Mary's skills in life coaching, a uniquely entwined and solid business union was built based upon trust and driven by a passion to supply high quality, clinically proven, healthcare products. Their dynamic partnership is relied upon by many practitioners and patients, whom appreciate their efficient and timely responses to all enquiries with their open, helpful and friendly manner.

Mary and Julie are recommended suppliers of The Acupuncture Association of Chartered Physiotherapists (AACP) and Corporate members of MLDuk and Sponsors of The National Lymphoedema Framework Ireland.

Company incorporation of PhysioPod® UK Ltd took place in July 2006, when the company was set up to exclusively supply DEEP OSCILLATION®, an unknown treatment modality in the UK and the Republic of Ireland.

Contact:
Mary Fickling
PhysioPod UK Limited and Physio Equipment
Sherbrook Road
Daybrook, Nottingham
01159 167 685
info@physiopod.co.uk
http://www.physioequipment.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulsed High-Dose Magnetic Fields of More Than 1000 Gauss Generated with the Magcell® Arthro From Physio Equipment in UK here

News-ID: 840423 • Views:

More Releases from PhysioPod UK Limited

AQUA - A Medical Mystery Created and Photographed by GEMMA LEVINE Published on 1 …
AQUA is a unique and illuminating way for people to understand the lymphatic system. Each photograph is a different representation of water, accompanied by captions from Professor Peter Mortimer, Lymphatics expert at St George’s Hospital, London, to explain the biology behind the condition. All proceeds from book sales go to Lymphoedema research, in partnership with St George’s Hospital Charity. Foreword by PROFESSOR PETER MORTIMER MD FRCP, Preface by DAME JUDI
Sandy Sanghera Adds DEEP OSCILLATION® To Holistic, Remedial And Beauty Treatmen …
After reading about DEEP OSCILLATION® in Empower Magazine, Sandy rang PhysioPod® on 18th September. By 3rd October, training had been completed in Nottingham with Julie Soroczyn and DEEP OSCILLATION® installed and in use in Sandy's Holistic Therapy Clinic in Solihull. Nottingham, Nottinghamshire, United Kingdom., October 20, 2017 -- After reading about DEEP OSCILLATION® in Empower Magazine, Sandy rang PhysioPod® on 18th September. By 3rd October, training had been completed in Nottingham

More Releases for MAGCELL®

Ultimate Chemicals® Featured in Manufacturing Marvels® on The Fox Business Net …
MOORE, OK., Oct. 8, 2021/ -- Ultimate Chemicals® Inc., an integrated manufacturer and supplier of chemicals and related services, is pleased to announce it will be showcased in a broadcast of Manufacturing Marvels® scheduled to air on October 14, 2021 at approximately 9:30-9:44 p.m. EST on The Fox Business Network® (FBN). Ultimate Chemicals has created their products to help restore surfaces to their optimum surface capability. Non-destructive to the surfaces to
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA and Intelligent Enterprise to Manufacturing, Consumer Products, Higher education, and research, Industrial machinery and components, Life sciences and Automotive Industries Chicago, IL, June 10, 2020 – Sunera Technologies, Inc announced that it had joined the SAP® PartnerEdge® program as a Re-sell & Services partner, through which it will resell SAP solutions to midsize organizations in North America. Through this engagement, SuneraTech
Infosim® announces release of StableNet® 7.5
Würzburg/Austin/Singapore, October 26th, 2015 – Infosim®, the technology leader in automated Service Fulfillment and Service Assurance solutions, today announced the release of version 7.5 of its award-winning software suite StableNet® for Telco and Enterprise customers. StableNet® 7.5 provides a significant number of powerful new features, including: • Dynamic Rule Generation (DRG); a new and revolutionary Fault Management concept • REST interface supporting the new StableNet® iPhone (and upcoming Android) app • Highly customizable dashboard in both the
GRAMMY® Performers Receiving AnthroSpa Logic® Announced
CHICAGO, IL- February, 2011- The Performers at the 53rd Annual GRAMMY® Awards, who will receive AnthroSpa Logic®, a luxury, 100% natural spa skin care and body care line inspired by the science of anthropology have been announced. The unique skin care line combines beauty secrets from around world and will be included in the in the Official VIP “Gift Bag” for the event, which takes place on Feb. 13,
American Megatrends Announces AMIBIOS®8 & Aptio®4.x Support for the Intel® Xe …
ATLANTA, GEORGIA - American Megatrends (AMI) is pleased to announce that its AMIBIOS®8 & Aptio®4.x products feature support for the new Intel® Xeon® 5500 Platform. The Intel® Xeon® 5500 platform combines the Intel® Xeon® Processor 5500 Series with the Intel® 5520 Chipset for embedded, storage, security and communications infrastructure applications in a wide range of form factors. There are four different processor options for this platform with seven year lifecycle support
CNUX .NET Providers for DB2® Earns IBM® DB2® Data Server Certification
CNUX Technologies Inc. announced today that CNUX .NET Providers for DB2® - Standard and Web Service Edition have achieved "Ready for IBM DB2 Data Server Software" status. With this designation CNUX customers can be assured that CNUX .NET Providers interacts and operates seamlessly with IBM® DB2® software. The "Ready for IBM DB2 Data Server Software" program is a process designed for independent software vendors (ISVs) and solution integrators to validate their